Tatekawa, Hiroyuki http://orcid.org/0000-0002-8050-4895
Uetani, Hiroyuki http://orcid.org/0000-0002-0547-1210
Hagiwara, Akifumi http://orcid.org/0000-0001-5277-3249
Yao, Jingwen http://orcid.org/0000-0002-8828-1841
Oughourlian, Talia C. http://orcid.org/0000-0001-8133-2928
Ueda, Issei http://orcid.org/0000-0002-3667-1151
Raymond, Catalina http://orcid.org/0000-0003-2757-439X
Lai, Albert http://orcid.org/0000-0002-7265-2986
Cloughesy, Timothy F. http://orcid.org/0000-0002-8656-7483
Nghiemphu, Phioanh L. http://orcid.org/0000-0003-4064-6079
Liau, Linda M. http://orcid.org/0000-0002-4053-0052
Bahri, Shadfar http://orcid.org/0000-0002-2622-389X
Pope, Whitney B. http://orcid.org/0000-0003-4803-1992
Salamon, Noriko http://orcid.org/0000-0002-3520-9467
Ellingson, Benjamin M. http://orcid.org/0000-0002-2764-6640
Funding for this research was provided by:
Society of nuclear medicine and molecular imaging
American Cancer Society (ACS) Research Scholar Grant (RSG-15-003-01-CCE)
American Brain Tumor Association (ABTA) Research Collaborators Grant (ARC1700002)
National Brain Tumor Society (NBTS) Research Grant
NIH/NCI UCLA Brain Tumor SPORE (1P50CA211015-01A1)
NIH/NCI UCLA Brain Tumor SPORE (1P50CA211015-01A1, 1P50CA211015-01A1, 1P50CA211015-01A1)
NIH/NCI (1R21CA223757-01)
Article History
Received: 18 January 2021
Accepted: 1 March 2021
First Online: 11 March 2021
Declaration
:
: Ellingson—Advisory Board—Hoffman La-Roche; Siemens; Nativis; Medicenna; MedQIA; Bristol-Myers Squibb; Imaging Endpoints; Agios. Paid Consultant—Nativis; MedQIA; Siemens; Hoffman La-Roche; Imaging Endpoints; Medicenna; Agios. Grant Funding—Hoffman La-Roche; Siemens; Agios; Janssen. Ellingson also holds a patent on this technology (US Patent #15/577,664; International PCT/US2016/034886). Cloughesy—Advisory Board—Roche/ Genentech, Amgen, Tocagen, NewGen, LPath, Proximagen, Celgene, Vascular Biogenics Ltd, Insys, Agios, Cortice Bioscience, Pfizer, Human Longevity, BMS, Merck, Notable Lab, MedQIA.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent was obtained from all individual participants to have their imaging, clinical, and molecular data included in our research database (IRB IRB#10-000655).